Prototype Project SCADA on Hemodialysis Mixing Tank Operation
Abstract
Pharmaceutical companies are an example of an industrial sector that uses technology-based systems in its production process. In this research the author will develop a SCADA (Supervisory Control Acquisition Data) system as a platform to solve several problems that are present in pharmaceutical production, namely in the drug production process using hemodilysis mixing tanks.
The method that the author uses for this research is experimental research and data collection methods, which use the independent variables of the study, water level control and temperature control, while the independent variables related to the system reading results are displayed on the SCADA screen.
Based on the results of mathematical calculations, it can be concluded that the production process using the SCADA system produces a more efficient time with a total time difference of 38 minutes/batch. Operations using SCADA technology within 24 hours were able to produce 4 batches of Infusion Bags, while using the conventional system only 3 batches. Operational needs using SCADA technology will generate more benefits in terms of cost and time, creating more effective and efficient work system for the company.
Downloads
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike International License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Copyright without Restrictions
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the IJNMT or its Editorial Staff. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
